VCCBH News

Pilot Grant Award Recipients 2021

October 1, 2021 by Office of the VCCBH

It is with great pleasure that we announce the recipients of our inaugural Vermont Center for Cardiovascular and Brain Health Pilot Grant Award, Drs Yangguang Ou and David Punihaole.

It is with great pleasure that we announce the recipients of our inaugural Vermont Center for Cardiovascular and Brain Health Pilot Grant Award, Drs Yangguang Ou and David Punihaole.

Drs Ou and Punihaole are newly appointed Assistant Professors in the Department of Chemistry and are Pipeline Investigators in our Center. Their work will focus on the use of novel chemical imaging and rapid electrochemical sensing techniques to assess the pathophysiology of variant amyloid-β fibrils involved in Alzheimer’s Disease and Cerebral Amyloid Angiopathy and is summarized below:

_______

Abnormal function of brain blood vessels and loss of function of brain cells contribute to cognitive decline in older people. These abnormalities are present in two related brain diseases, Alzheimer’s disease and cerebral amyloid angiopathy. In these disorders, fibrils made up of amyloid-b (Ab) peptides are deposited in the brain. These fibrils damage the cells and blood vessels in the brain.  They may cause these diseases and contribute to their severity. This research has two aims. We will develop bioanalytical methods to 1) monitor how Ab fibrils interact with cell membranes in brain tissue and brain blood vessels, and 2) measure molecules released from these interactions that contribute to cell death.  We will develop novel chemical imaging and rapid electrochemical sensing techniques to do this. We hope to understand the effects of Ab fibrils on the progression and outcome of Alzheimer’s disease and cerebral amyloid angiopathy. Our long-term goal is to better understand causes of Alzheimer’s disease and cerebral amyloid angiopathy.  We hope that this will guide the development of medications for prevention and treatment of these conditions.

This award, supported wholly by funds from UVM entities, provides $200,000 over 2 years to fund meritorious research from early career faculty. We are very grateful to Deans from the Colleges of Medicine, Nursing & Health Sciences, Arts & Sciences, Engineering & Mathematical Sciences, and the Graduate College, as well as the Cardiovascular Research Institute of Vermont, for their support of this program. In addition, we would like to acknowledge matching fund support from the Department of Chemistry.
_______

Please watch for our announcement for the next VCCBH Pilot Grant Award opportunity. We will announce this in December and will be accepting letters of intent until February 4, 2021. As for this year, we will be seeking applications from pairs of early career investigators, so now is the time to start thinking about your application.

Recent Stories and Publications Featuring VCCBH Members

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted December 4, 2024

On November 16, Larner Assistant Professor of Medicine Debora Kamin Mukaz, Ph.D., M.S., moderated a panel on science policy advocacy titled “How can we engage scientists from historically underrepresented backgrounds in policymaking and advocacy?” at the American Heart Association’s Scientific Sessions 2024 conference in Chicago. The panelists were AHA President Keith Churchwell, M.D.; past AHA President Michelle Albert, M.D., M.P.H.; Emelia Benjamin, M.D., Sc.M., associate provost and professor of medicine and epidemiology at Boston University; and Carl Streed, Jr., M.D., M.P.H., associate professor of medicine at Boston University.

Research on spider brain leads to groundbreaking Alzheimer’s discovery

Posted December 3, 2024

Neurodegeneration in spider brain leads Vermont neuroscientists to groundbreaking discovery in Alzheimer’s-affected human brains 
Vermont Business Magazine Researchers from Saint Michael’s College and the University of Vermont have made a groundbreaking new discovery that provides a better understanding of how Alzheimer’s disease develops in the human brain.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 23, 2024

In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow return to normal after neural activity.

The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort

Posted October 23, 2024

Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration.

Assessing prenatal and early childhood social and environmental determinants of health in the HEALthy Brain and Child Development Study (HBCD)

Posted October 23, 2024

The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood.

Health Watch: UVM researchers unlock secrets of brain blood flow in cognitive health

Posted October 16, 2024

Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it.

UVM at the Forefront of Stroke and Brain Health Research

Posted October 14, 2024

REGARDS Study Grant Renewed: UVM’s Continued Contributions to Research on Stroke Disparities by Race and Geography. Investigators at the Larner College of Medicine are receiving a $10.1 million multi-year grant from the National Institutes of Health (NIH) to continue their 23-year program studying stroke and cognitive disorders in the United States.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 2, 2024

Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted August 21, 2024

Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5 at Magdalen College in Oxford, United Kingdom.